1) ganciclovir capsule
更昔洛韦胶囊
1.
OBJECTIVE To analyze and compare the efficacy and safety of ganciclovir capsules and ganciclovir for injection for treatment of cytomegalovirus infection following bone marrow transplantation.
目的:分析比较更昔洛韦胶囊与注射用更昔洛韦于骨髓移植术后人巨细胞病毒(CMV)感染的有效性与安全性。
2) Famciclovir capsules
泛昔洛韦胶囊
4) ganciclovir
更昔洛韦
1.
Compatible stabilities of glucose and sodium chloride potassium chloride injection mixing with aciclovir and ganciclovir for injection;
葡萄糖氯化钠钾注射液与注射用阿昔洛韦、更昔洛韦配伍的稳定性
2.
Preparation and Observation of Dissolution Characteristics of Ganciclovir Dispersible Tablets in Vitro;
更昔洛韦分散片的研制及体外溶出特性
5) Valganciclovir
缬更昔洛韦
1.
Determination the plasma concentration of valganciclovir and study on its pharmacokinetics in healthy volunteers;
液相色谱-串联质谱法测定缬更昔洛韦血药浓度及其在健康人体的药代动力学研究
2.
A new oral antiviral drug——valganciclovir;
口服抗病毒新药——缬更昔洛韦
3.
Review on the Synthesis of the New Antivirus Agent Valganciclovir;
新型抗病毒药物缬更昔洛韦的合成综述
6) Ganciclovir sodium
更昔洛韦钠
补充资料:更昔洛韦
分子式:C9H13N5O4
分子量:255.23
CAS号:82410-32-0
性质:暂无
制备方法:暂无
用途:抗病毒药。
分子量:255.23
CAS号:82410-32-0
性质:暂无
制备方法:暂无
用途:抗病毒药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条